Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
1.130
-0.030 (-2.59%)
At close: Dec 5, 2025, 4:00 PM EST
1.122
-0.008 (-0.74%)
After-hours: Dec 5, 2025, 7:58 PM EST
Pasithea Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | - | - | - | - | 0.02 | - |
| Cost of Revenue | - | - | - | - | 0.02 | - |
| Gross Profit | - | - | - | - | -0 | - |
| Selling, General & Admin | 7.12 | 7.05 | 7.88 | 9.92 | 4.51 | 0.06 |
| Research & Development | 6.75 | 7.2 | 8.1 | 2.67 | - | - |
| Operating Expenses | 13.86 | 14.25 | 15.98 | 12.59 | 4.51 | 0.06 |
| Operating Income | -13.86 | -14.25 | -15.98 | -12.59 | -4.51 | -0.06 |
| Interest Expense | - | - | - | - | -0 | - |
| Interest & Investment Income | 0.23 | 0.42 | 0.42 | - | - | - |
| Other Non Operating Income (Expenses) | 0.14 | -0.08 | 0.06 | 1.85 | 2.33 | - |
| EBT Excluding Unusual Items | -13.5 | -13.9 | -15.51 | -10.74 | -2.17 | -0.06 |
| Legal Settlements | - | - | - | -1 | - | - |
| Other Unusual Items | - | - | - | 0.01 | - | - |
| Pretax Income | -13.49 | -13.9 | -15.51 | -11.73 | -2.17 | -0.06 |
| Earnings From Continuing Operations | -13.49 | -13.9 | -15.51 | -11.73 | -2.17 | -0.06 |
| Earnings From Discontinued Operations | - | - | -0.45 | -2.21 | - | - |
| Net Income | -13.49 | -13.9 | -15.96 | -13.94 | -2.17 | -0.06 |
| Net Income to Common | -13.49 | -13.9 | -15.96 | -13.94 | -2.17 | -0.06 |
| Shares Outstanding (Basic) | 4 | 1 | 1 | 1 | 1 | 0 |
| Shares Outstanding (Diluted) | 4 | 1 | 1 | 1 | 1 | 0 |
| Shares Change (YoY) | 298.39% | -10.64% | -2.83% | 142.65% | 41.29% | - |
| EPS (Basic) | -3.25 | -12.69 | -13.01 | -11.04 | -4.18 | - |
| EPS (Diluted) | -3.25 | -12.69 | -13.01 | -11.04 | -4.18 | - |
| Free Cash Flow | -12.26 | -13.92 | -13.46 | -13.8 | -3.2 | -0.06 |
| Free Cash Flow Per Share | -2.95 | -12.70 | -10.97 | -10.93 | -6.14 | -0.16 |
| Gross Margin | - | - | - | - | -14.69% | - |
| Operating Margin | - | - | - | - | -29925.73% | - |
| Profit Margin | - | - | - | - | -14430.49% | - |
| Free Cash Flow Margin | - | - | - | - | -21216.05% | - |
| EBITDA | -13.19 | -13.6 | -15.33 | -12.58 | -4.51 | - |
| D&A For EBITDA | 0.67 | 0.65 | 0.65 | 0.01 | 0 | - |
| EBIT | -13.86 | -14.25 | -15.98 | -12.59 | -4.51 | -0.06 |
Source: S&P Capital IQ. Standard template.
Financial Sources.